Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 156.25 | 67.09 | 212.00 | 200.75 | 1.0560 | 1.0702 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 168.00 | 200.75 | 0.8369 | 0.7870 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 486.00 | 568.50 | 0.8549 | 0.8647 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 622.00 | 568.50 | 1.0941 | 1.0820 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 312.50 | 120.45 | 138.00 | 568.50 | 0.2427 | 0.0626 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 389.00 | 568.50 | 0.6843 | 0.6882 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 603.00 | 568.50 | 1.0607 | 1.0533 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 312.50 | 120.45 | 696.00 | 568.50 | 1.2243 | 1.1892 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 312.50 | 120.45 | 590.00 | 568.50 | 1.0378 | 1.0334 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 312.50 | 120.45 | 495.00 | 568.50 | 0.8707 | 0.8801 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 731.00 | 568.50 | 1.2858 | 1.2377 | |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 657.00 | 568.50 | 1.1557 | 1.1335 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 312.50 | 120.45 | 770.00 | 568.50 | 1.3544 | 1.2903 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 816.00 | 568.50 | 1.4354 | 1.3504 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 740.00 | 568.50 | 1.3017 | 1.2500 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 312.50 | 120.45 | 132.00 | 568.50 | 0.2322 | 0.0417 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 312.50 | 120.45 | 630.00 | 568.50 | 1.1082 | 1.0939 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 312.50 | 120.45 | 379.00 | 568.50 | 0.6667 | 0.6687 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 312.50 | 120.45 | 357.00 | 568.50 | 0.6280 | 0.6247 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 459.00 | 568.50 | 0.8074 | 0.8177 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 499.00 | 568.50 | 0.8778 | 0.8868 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 457.00 | 568.50 | 0.8039 | 0.8142 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 312.50 | 120.45 | 564.00 | 568.50 | 0.9921 | 0.9929 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 352.00 | 568.50 | 0.6192 | 0.6145 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 523.00 | 568.50 | 0.9200 | 0.9269 |